Pharmacoepidemiology: A key complementary tool to evaluate the paediatric exposome
- PMID: 35821649
- DOI: 10.1111/ppe.12907
Pharmacoepidemiology: A key complementary tool to evaluate the paediatric exposome
Comment on
-
Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children.Paediatr Perinat Epidemiol. 2022 Sep;36(5):726-737. doi: 10.1111/ppe.12870. Epub 2022 Feb 16. Paediatr Perinat Epidemiol. 2022. PMID: 35172017 Free PMC article.
References
REFERENCES
-
- Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science. 2010;330(6003):460-461. doi:10.1126/science.1192603
-
- Bundy DAP, de Silva N, Horton S, et al. Investment in child and adolescent health and development: key messages from disease control priorities, 3rd edition. Lancet. 2018;391(10121):687-699. doi:10.1016/S0140-6736(17)32417-0
-
- Schaffer AL, Bruno C, Buckley NA, et al. Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children. Paediatr Perinat Epidemiol. 2022:1-12. doi:10.1111/ppe.12870
-
- Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther. 2012;91(5):796-801. doi:10.1038/clpt.2012.26
-
- Taine M, Offredo L, Weill A, Dray-Spira R, Zureik M, Chalumeau M. Pediatric outpatient prescriptions in countries with advanced economies in the 21st century: a systematic review. JAMA Netw Open. 2022;5(4):e225964. doi:10.1001/jamanetworkopen.2022.5964
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
